Canderova Tablet 20/32 mg

Adult dose

Candesartan Cilexetil 1. Essential Hypertension - The recommended initial and maintenance dose is 8 to 16 mg orally once daily. If insufficient control is observed after 4 weeks of treatment at 16 mg, the dose may be increased up to 32 mg once daily. In patients with reduced intravascular effective blood volume: initiate with 4 mg. In patients with renal dysfunction: initiate with 4 mg and adjust based on patient response. In patients with liver dysfunction: initiate with 2 mg once daily. 2. Heart Failure - The initial dose is recommended as 4 mg once daily. After an interval of more than 2 weeks, doses may be doubled based on patient tolerance up to a maximum of 32 mg once daily. If the patient is elderly, with reduced intravascular effective blood volume, renal dysfunction, or mild to moderate liver dysfunction, dose adjustment is not necessary.

Child dose

The safety and efficacy in individuals under 18 years of age have not been established.

This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. This medication is contraindicated in patients with a known allergy to it, those with severe liver function impairment, and those with certain genetic lactase metabolism disorders. Special caution should be taken in elderly patients, those with impaired kidney function, and those with hyperkalemia, and regular blood tests and liver function tests should be performed under a doctor's advice. If symptoms such as myalgia or muscle weakness occur, immediate consultation with a physician is necessary, and in severe cases, it may be required to discontinue the medication. Interactions may occur if taken with other antihypertensive medications or certain lipid-lowering drugs; therefore, it is essential to inform the doctor or pharmacist of any other medications being taken. Caution is warranted as dizziness or fatigue may occur when driving or operating machinery. Women who could become pregnant should use appropriate contraception before taking this medication, and breastfeeding women are advised to avoid it. In cases of overdose, seek medical attention immediately, and since there is no specific antidote, treatment will be symptomatic. The safety and efficacy of this medication in children have not been established, thus it is not recommended. Keep the medication out of reach of children and do not transfer it from its original container to another.

Serious side effects

Hives, angioedema (face, lips, tongue, throat, etc.), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attacks, respiratory difficulties accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness

Mild side effects

• Headache
• dizziness
• nasopharyngitis
• itching
• dermatitis
• nausea
• dyspepsia
• fatigue
• myalgia
• arthralgia

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance

Pink round film-coated tablet

Package unit

30 tablets (10 tablets/PTP X 3) - 30 tablets/PTP [30 tablets (10 tablets/PTP X 3)]